Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\24867676
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Curr+Opin+Nephrol+Hypertens
2014 ; 23
(4
): 331-9
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
?Klotho and vascular calcification: an evolving paradigm
#MMPMID24867676
Hu MC
; Kuro-o M
; Moe OW
Curr Opin Nephrol Hypertens
2014[Jul]; 23
(4
): 331-9
PMID24867676
show ga
PURPOSE OF REVIEW: Cardiovascular disease remains the single most serious
contributor to mortality in chronic kidney disease (CKD). Although conventional
risk factors are prevalent in CKD, both cardiomyopathy and vasculopathy can be
caused by pathophysiologic mechanisms specific to the uremic state. CKD is a
state of systemic ?Klotho deficiency. Although the molecular mechanism of action
of ?Klotho is not well understood, the downstream targets and biologic functions
of ?Klotho are astonishingly pleiotropic. An emerging body of literature links
?Klotho to uremic vasculopathy. RECENT FINDINGS: The expression of ?Klotho in the
vasculature is controversial because of conflicting data. Regardless of whether
?Klotho acts as a circulating or resident protein, there are good data
associating changes in ?Klotho levels with vascular pathology including vascular
calcification and in-vitro data of the direct action of ?Klotho on both the
endothelium and vascular smooth muscle cells in terms of cytoprotection and
prevention of mineralization. SUMMARY: It is critical to understand the
pathogenic role of ?Klotho on the integral endothelium-vascular smooth muscle
network rather than each cell type in isolation in uremic vasculopathy, as
?Klotho can serve as a potential prognostic biomarker and a biological
therapeutic agent.